Himadri Speciality Chemical (500184) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
28 Apr, 2026Executive summary
Achieved record financial performance in FY 2026, with highest ever EBITDA of ₹1,006 crore and PAT of ₹755 crore, driven by value-added solutions, operational efficiency, and new product launches.
Commissioned India's first commercial-scale anode material facility (200 MTPA) and expanded specialty carbon black capacity, positioning as a global leader.
Strategic investments and partnerships in lithium-ion battery materials, including collaborations with Sicona, IBC, and Invati, to drive innovation and future growth.
Revived Birla Tyres, contributing INR 187 crore in FY 2026, with plans to scale to INR 3,000 crore in four years.
Board recommended a final dividend of ₹0.80 per share for FY26, subject to shareholder approval.
Financial highlights
FY 2026 consolidated revenue: ₹4,661 crore; EBITDA: ₹1,006 crore (up 19% YoY); PAT: ₹755 crore (up 36% YoY); Q4 FY 2026 revenue: ₹1,288 crore, up 14% YoY.
Standalone FY 2026 revenue: ₹4,405 crore; EBITDA: ₹978 crore (up 16% YoY); PAT: ₹750 crore (up 34% YoY).
Standalone EPS for FY 2026 was ₹15.05 (basic); consolidated EPS was ₹15.08 (basic).
Net positive cash balance of ₹121 crore as of March 31, 2026.
Total assets increased to ₹6,087.26 crore (standalone) and ₹6,306.39 crore (consolidated) as of March 31, 2026.
Outlook and guidance
Expect both top line and bottom line growth in FY 2027, with margin expansion from new capacities and full-year operations of expanded specialty carbon black and Birla Tyres.
Committed to doubling PAT from FY 2025 (INR 555 crore) to over INR 1,100 crore by FY 2028.
Forward integration into anthraquinone and carbazole, and commercial LFP cathode plant targeted for Q3 FY27.
Expansion into China via a new wholly owned step-down subsidiary is planned to drive global growth.
No specific annual revenue or margin guidance provided for FY 2027.
Latest events from Himadri Speciality Chemical
- PAT up 41% YoY in 9MFY26, with strong capex, margin gains, and sustainability accolades.500184
Q3 25/2621 Jan 2026 - Record FY25 growth, strong specialty and battery expansions, and robust future outlook.500184
Q4 24/2521 Dec 2025 - Record profitability and margin growth in H1 FY26 driven by specialty products and expansion.500184
Q2 25/2624 Oct 2025 - Record profit and margin growth achieved despite lower revenue, with major expansion underway.500184
Q1 25/2614 Oct 2025 - Record Q1FY25 growth, core segment strength, and strategic expansion drive future prospects.500184
Q1 24/2528 Aug 2025 - Record growth, strong cash, and strategic expansion in battery and specialty segments.500184
Q2 24/2528 Aug 2025 - Record financial growth, major capex, and strategic expansion with new subsidiaries and acquisitions.500184
Q3 24/2528 Aug 2025